121031-01-4

Basic information

• Product Name: 5-bromo-β,β,2,4-tetramethyl-3,6-dioxo-1,4-cyclohexadiene-1-propanoic acid
• Synonyms: 5-bromo-β,β,2,4-tetramethyl-3,6-dioxo-1,4-cyclohexadiene-1-propanoic acid
• CAS NO: 121031-01-4
• Molecular Weight: 315.164
• Mol File: 121031-01-4.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 5-bromo-β,β,2,4-tetramethyl-3,6-dioxo-1,4-cyclohexadiene-1-propanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 5-bromo-β,β,2,4-tetramethyl-3,6-dioxo-1,4-cyclohexadiene-1-propanoic acid(121031-01-4)
• EPA Substance Registry System: 5-bromo-β,β,2,4-tetramethyl-3,6-dioxo-1,4-cyclohexadiene-1-propanoic acid(121031-01-4)

Safety Data

• Hazardous Substances Data: 121031-01-4(Hazardous Substances Data)

Upstream product

• 654-42-2 1,4-dihydroxy-2,6-dimethylbenzene 
• 527-61-7 2,6-dimethyl-1,4-benzoquinone 
• 409316-82-1 2-bromo-3,5-dimethyl-hydroquinone 
• 409316-81-0 2-bromo-3,5-dimethylcyclohexane-2,5-diene-1,4-dione 
• 541-47-9 3-Methylbutenoic acid 
• 265645-64-5 (S)-3-{4-[Bis-(2-chloro-ethyl)-amino]-phenyl}-2-[3-(5-bromo-2,4-dimethyl-3,6-dioxo-cyclohexa-1,4-dienyl)-3-methyl-butyrylamino]-propionic acid methyl ester 
• 50442-68-7 6-hydroxy-4,4,5,7-tetramethyl-3,4-dihydrocoumarin 

Downstream Products

• 121031-06-9 N,N-dimethyl-β,β,2,4-tetramethyl-5-(N-methylamino)-3,6-dioxo-1,4-cyclohexadiene-1-propanamide 
• 265645-64-5 (S)-3-{4-[Bis-(2-chloro-ethyl)-amino]-phenyl}-2-[3-(5-bromo-2,4-dimethyl-3,6-dioxo-cyclohexa-1,4-dienyl)-3-methyl-butyrylamino]-propionic acid methyl ester 
• 121031-02-5 β,β,2,4-tetramethyl-5-(N-methylamino)-3,6-dioxo-1,4-cyclohexadiene-1-propanoic acid 

Relevant articles and documents

Syntheses and antibacterial activity of N -acylated ciprofloxacin derivatives based on the trimethyl lock

Several N-acyl ciprofloxacin quinone derivatives based on a trimethyl lock structure were synthesized, and their in vitro antibacterial activity against a panel of clinically relevant bacteria was evaluated. A few new analogues displayed enhanced activity

Water-soluble triptolide derivative and preparation method and application thereof

The invention discloses a water-soluble triptolide derivative and a preparation method and application thereof. The chemical structural formula of the water-soluble triptolide derivative is as shown in the specification, wherein n=2,3,4..., and n is a pos

Reductive activation of conformationally-constrained, anticancer drug delivery systems

Redox-active substituents were used to modulate reduction potentials in conformationally-constrained, drug delivery systems. The extent of drug delivery was proportional to the degree of reductive activation, which was influenced by the electronic properties of the substituents. Such reductively-activated carrier systems can be used to achieve controlled drug delivery to bioreductive regions in hypoxic solid tumors.